SCHEMBL19081972

SCHEMBL19081972

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5cc6sc7ccccc7c6c6c5oc5ccc7ccccc7c56)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.35
CYP1A1 P04798 2/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A2 P05177 2/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
AHR P35869 1/20 0.35
S1PR5 Q9H228 7/20 0.34
S1PR4 O95977 6/20 0.34
CYP1B1 Q16678 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081904 0.94 ABCG2 (0.40) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL17945679 0.90 S1PR5 (0.35) CYP1A1CYP1A2S1PR5S1PR4CYP1B1
SCHEMBL19081830 0.89 ABCG2 (0.39) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL17932272 0.84 S1PR5 (0.35) CYP1A1CYP1A2S1PR5S1PR4CYP1B1
SCHEMBL19082025 0.83 ABCG2 (0.38) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19081581 0.83 TDP1 (0.39) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL19082027 0.83 CYP1A1 (0.39) ABCG2CYP1A1CYP1A2S1PR5S1PR4
SCHEMBL19076716 0.82 S1PR5 (0.33) ABCG2CYP1A1S1PR5S1PR4CYP1B1
SCHEMBL19076722 0.82 CYP1A1 (0.38) ABCG2CYP1A1PAX8CYP1A2S1PR5
SCHEMBL19081815 0.81 CYP1A1 (0.42) ABCG2CYP1A1CYP1A2S1PR5S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.